The strongest susceptibility genes for the development of systemic lupus erythematosus (SLE) in humans are null mutants of classical pathway complement proteins. There is a hierarchy of disease susceptibility and severity according to the position of the missing protein in the activation pathway, with the severest disease associated with C1q deficiency. Here we demonstrate, using novel in vivo models of apoptotic cell clearance during sterile peritonitis, a similar hierarchical role for classical pathway complement proteins in vivo in the clearance of apoptotic cells by macrophages. Our results constitute the first demonstration of an impairment in the phagocytosis of apoptotic cells by macrophages in vivo in a mammalian system. Apoptotic cells are thought to be a major source of the autoantigens of SLE, and impairment of their removal by complement may explain the link between hereditary complement deficiency and the development of SLE.
Skip Nav Destination
Article navigation
7 August 2000
Article|
July 31 2000
A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo
Philip R. Taylor,
Philip R. Taylor
aRheumatology Section, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Search for other works by this author on:
Anna Carugati,
Anna Carugati
aRheumatology Section, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Search for other works by this author on:
Valerie A. Fadok,
Valerie A. Fadok
cDepartment of Pediatrics, National Jewish Medical Research Center, Denver, Colorado 80206
Search for other works by this author on:
H. Terence Cook,
H. Terence Cook
bDepartment of Histopathology, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Search for other works by this author on:
Mark Andrews,
Mark Andrews
dDivision of Renal and Inflammatory Disease, University Hospital, Nottingham NG7 2UH, United Kingdom
Search for other works by this author on:
Michael C. Carroll,
Michael C. Carroll
eCenter for Blood Research, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02165
Search for other works by this author on:
John S. Savill,
John S. Savill
fCentre for Inflammation Research, University of Edinburgh Medical School, Edinburgh EH3 9YW, United Kingdom
Search for other works by this author on:
Peter M. Henson,
Peter M. Henson
cDepartment of Pediatrics, National Jewish Medical Research Center, Denver, Colorado 80206
Search for other works by this author on:
Marina Botto,
Marina Botto
aRheumatology Section, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Search for other works by this author on:
Mark J. Walport
Mark J. Walport
aRheumatology Section, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Search for other works by this author on:
Philip R. Taylor
aRheumatology Section, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Anna Carugati
aRheumatology Section, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Valerie A. Fadok
cDepartment of Pediatrics, National Jewish Medical Research Center, Denver, Colorado 80206
H. Terence Cook
bDepartment of Histopathology, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Mark Andrews
dDivision of Renal and Inflammatory Disease, University Hospital, Nottingham NG7 2UH, United Kingdom
Michael C. Carroll
eCenter for Blood Research, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02165
John S. Savill
fCentre for Inflammation Research, University of Edinburgh Medical School, Edinburgh EH3 9YW, United Kingdom
Peter M. Henson
cDepartment of Pediatrics, National Jewish Medical Research Center, Denver, Colorado 80206
Marina Botto
aRheumatology Section, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Mark J. Walport
aRheumatology Section, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, United Kingdom
Abbreviations used in this paper: ANOVA, analysis of variance; SLE, systemic lupus erythematosus.
Received:
January 31 2000
Revision Requested:
May 19 2000
Accepted:
May 23 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 192 (3): 359–366.
Article history
Received:
January 31 2000
Revision Requested:
May 19 2000
Accepted:
May 23 2000
Citation
Philip R. Taylor, Anna Carugati, Valerie A. Fadok, H. Terence Cook, Mark Andrews, Michael C. Carroll, John S. Savill, Peter M. Henson, Marina Botto, Mark J. Walport; A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo. J Exp Med 7 August 2000; 192 (3): 359–366. doi: https://doi.org/10.1084/jem.192.3.359
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement